Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Distractibility in Progressive Supranuclear Palsy
NCT00139373Phase 2Unknown
- Sponsor
- La Pitié-Salpêtrière Hospital
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of donepezil in progressive supranuclear palsy (PSP), sponsored by La Pitié-Salpêtrière Hospital. Primary endpoint: Distractibility. Status: unknown.
02
Drugs
donepezil
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT00139373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139373.